Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Eagan

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Oncology|January 1, 1981
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancerE T Creagan, R T Eagan, L K Kvols
Medical and Pediatric Oncology|January 1, 1978
Preliminary study of a combination of adriamycin, bleomycin, and diamminedichloroplatinum in advanced cancerD A Decker, J H Edmonson, R T Eagan
Annals of Internal Medicine|January 1, 1973
Cancer immunotherapyR T Eagan, F C Sparks, D L Morton
Cancer Treatment Reports|November 1, 1979
VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup reportJ C Britell, R T Eagan, R E Lee
Cancer Treatment Reports|March 1, 1977
Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary reportL K Kvols, R T Eagan, R P Myers
Cancer Treatment Reports|May 1, 1977
Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancerH I Saiontz, R J Dalton, R T Eagan
Cancer|November 15, 1981
Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancerT R Lininger, T R Fleming, R T Eagan
Cancer|March 1, 1983
The effect of CNS metastases on the survival of patients with small cell cancer of the lungG A van Hazel, M Scott, R T Eagan
Cancer Treatment Reports|January 1, 1976
Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancerR T Eagan, R G Hahn, R P Myers
Oncology|January 1, 1976
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancerR T Eagan, D L Ahmann, H F Bisel
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Oncology|January 1, 1981
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancerE T Creagan, R T Eagan, L K Kvols
Medical and Pediatric Oncology|January 1, 1978
Preliminary study of a combination of adriamycin, bleomycin, and diamminedichloroplatinum in advanced cancerD A Decker, J H Edmonson, R T Eagan
Annals of Internal Medicine|January 1, 1973
Cancer immunotherapyR T Eagan, F C Sparks, D L Morton
Cancer Treatment Reports|November 1, 1979
VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup reportJ C Britell, R T Eagan, R E Lee
Cancer Treatment Reports|March 1, 1977
Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary reportL K Kvols, R T Eagan, R P Myers
Cancer Treatment Reports|May 1, 1977
Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancerH I Saiontz, R J Dalton, R T Eagan
Cancer|November 15, 1981
Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancerT R Lininger, T R Fleming, R T Eagan
Cancer|March 1, 1983
The effect of CNS metastases on the survival of patients with small cell cancer of the lungG A van Hazel, M Scott, R T Eagan
Cancer Treatment Reports|January 1, 1976
Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancerR T Eagan, R G Hahn, R P Myers
Oncology|January 1, 1976
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancerR T Eagan, D L Ahmann, H F Bisel
Pageof 11